{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-000673","form_type":"8-K/A","ticker":"DHTI","cik":"0000725394","company_name":"Dalrada Technology Group, Inc.","filed_at":"2026-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.588581+00:00","generated_at":"2026-05-16T05:48:42.991751+00:00","sec_items":["2.03","1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"Dalrada Tech Group amends 8-K: subsidiary Genefic secures up to $25M financing; CEO personal guaranty","bullets":["Corrected total commitment from $20M to $25M: $20M SBLC agreement + $5M ARL receivables facility.","CEO Brian Bonar provides unlimited personal guaranty; parent company pledges substantially all assets.","Availability period through Dec 31, 2030; fees include $140k cash, $165k note, $225k warrant for 5% equity.","Financing supports Genefic's healthcare specialty pharmacy operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-000673","json":"https://secwatch.observer/filing/0001683168-26-000673.json","markdown":"https://secwatch.observer/filing/0001683168-26-000673.md","text":"https://secwatch.observer/filing/0001683168-26-000673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/725394/000168316826000673/0001683168-26-000673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/725394/000168316826000673/dalrada_8ka1.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:48:42.991751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}